Work

The expanding universe of type I regulatory T cell biology: a new role in cancer immunotherapy

Year: 2024

Type: article

Abstract: In this article, we discuss new findings which suggest that type I regulatory T (Tr1) cells can interfere with cancer vaccine efficacy in mice by exerting strong regulatory control over antitumor immune responses.

Source: Immunology and Cell Biology

DOI: 10.1111/imcb.12822

Authors: Jason F Nideffer, Prasanna Jagannathan

Institutions: Stanford Medicine, Stanford University

Language: English

Topic: T-cell and B-cell Immunology

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institute of Allergy and Infectious Diseases

Award: Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infections

OpenAlex ID: W4402499930

FWCI:

Cites: 10

Cited by:

Related to: 10